French Version of Fear-Avoidance Component Scale (FACS-FR)
FACS-Fr
Psychometric Validation of the French Version of the Fear Avoidance Component Scale (FACS)
1 other identifier
interventional
50
1 country
1
Brief Summary
Chronic musculoskeletal disorders are global burden for economy. Fear-avoidance (FA) seems be a predictor for the transition from subacute to chronic pain. One of the most famous scales to access FA is the Tampa scale of kinesiophobia, but several responders think some items are not clear, too narrow or too general. A new scale, the Fear-Avoidance Components Scale (FACS) was developed by Neblett et al. in 2015 to assess FA. It is a comprehensive set of concepts that more effectively addresses all the essential issues of the FA concept than the current scales. The new scale comprehensively assesses all cognitive, emotional, and behavioral components related to the updated FA model by combining items from well-known scales in the context of the FA model with items on perceived injury-related victimization and blame. A French version of the FACS is currently lacking. The aim of this study is to provide a translation and validation of a French version of FACS in patients with musculoskeletal disorders.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 19, 2022
CompletedFirst Posted
Study publicly available on registry
February 1, 2022
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedMarch 28, 2023
March 1, 2023
1 year
January 19, 2022
March 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
FACS
The fear-avoidance component scale evaluating fear-avoidance (for all participants) 20 items range from 0-100
day 0
FACS
The fear-avoidance component scale evaluating fear-avoidance (for all participants) 20 items range from 0-100
day 7
TSK
Questionnaire evaluating kinesiophobia (for all participants) 17 items total score from 17-68
day 0
PCS
Pain catastrophizing scale (for all participants) 13 items total score from 0-52
day 0
HADS
Hospital anxiety and depression scale is a questionnaire evaluating anxiety and depression (for all participants) 2 subscales: anxiety (7 items) and depression (7 items) Total score 0-21 per subscale
day 0
Study Arms (1)
Chronic pain
EXPERIMENTALFear-avoidance components scale
Interventions
Diagnostic Test: Assessment of disability and behavior (by questionnaires)
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Current chronic pain complaint is not surgically treated (at least 6 weeks of pain)
- Not being currently treated by a physiotherapist for pain complaint
- French language is mother tongue
You may not qualify if:
- Pain from a non-musculoskeletal origin (e.g., tumour)
- Neurological disease
- Impaired cognition
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre de recherche du CHUS (CRCHUS)
Sherbrooke, Quebec, J1H 5N4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Guillaume Leonard, Pr
Université de Sherbrooke
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 19, 2022
First Posted
February 1, 2022
Study Start
February 1, 2022
Primary Completion
February 1, 2023
Study Completion
February 1, 2023
Last Updated
March 28, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share